![Man working on computer with sand clock](/sites/default/files/styles/oe_theme_medium_no_crop/public/2024-05/AdobeStock_595278401.jpeg?itok=XpO5A9v4)
The Real4Reg project aims to facilitate the implementation of the effective use of real-world data (#RWD) in regulatory decision-making and health technology assessment (#HTA). The Real4Reg consortium has launched a survey to find out more about the stakeholders’ views on needs, use and opinions on the topic of real-world data. Patients and Physicians, Academic organisations, Regulatory bodies, HTA, Pharmaceutical industry, Healthcare payers and insurance companies are welcome to submit their survey responses until 14 June 2024.
Relevant information: LinkedIn post with the survey link | Real4Reg
Details
- Publication date
- 24 May 2024
- Author
- European Medicines Agency